Charles River Laboratories reported 27.69 in PE Price to Earnings for its fiscal quarter ending in September of 2026.





Pe Change Date
Agilent 23.66 3.13 Jun/2026
Align Technology 17.17 4.64 Sep/2026
Bio-Rad Laboratories 48.85 38.84 Jun/2026
Bruker 53.51 6.97 Sep/2026
Cardinal Health 20.54 5.62 Sep/2026
Charles River Laboratories 27.69 30.58 Sep/2026
Cigna 11.69 0.34 Jun/2026
CVS Health 9.96 2.55 Sep/2026
Danaher 35.77 3.09 Sep/2026
Dentsply International 16.45 3.86 Sep/2026
Elevance Health 16.52 0.59 Sep/2026
Humana 24.28 13.21 Jun/2026
Illumina 70.8 21.82 Sep/2026
Incyte 54.54 40.08 Sep/2026
Intrexon 7.54 221.44 Dec/2021
IQVIA Holdings 29.03 7.58 Sep/2026
Laboratory Of America 22.15 1.69 Sep/2026
Lakefront Biotherapeutics 2.56 0.12 Sep/2026
Lonza 34.34 2.58 Dec/2025
McKesson 22 1.64 Sep/2026
Merck 17.21 4.47 Jun/2026
Mettler Toledo International 27.29 0.04 Jun/2026
Novartis 19.17 3.24 Sep/2026
Pfizer 15.2 3.72 Sep/2026
Quest Diagnostics 22.19 0.96 Sep/2026
Revvity 56.86 20.39 Sep/2026
Thermo Fisher Scientific 35.46 9.05 Sep/2026
United Therapeutics 19.41 0.26 Sep/2026
UnitedHealth 16.84 4.12 Sep/2026
Veradigm 11.15 4.63 Sep/2022
Waters 95.42 28.73 Sep/2026
West Pharmaceutical Services 40.64 1.99 Sep/2026